Core protein of hepatitis C virus induces cardiomyopathy

Circulation Research

Volumn 96, Issue 2, 2005, Pages 148-150

  Omura, Takashi ^a   Yoshiyama, Minoru ^a   Hayashi, Tetsuya ^b   Nishiguchi, Shuhei ^a   Kaito, Masahiko ^c   Horiike, Shinichiro ^c   Fukuda, Katsuhiko ^a   Inamoto, Sakiko ^b   Kitaura, Yasushi ^b   Nakamura, Yasuhiro ^a   Teragaki, Masakazu ^a   Tokuhisa, Takeshi ^d   Iwao, Hiroshi ^a   Takeuchi, Kazuhide ^a   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiomyopathy; Core protein; Hepatitis C virus

Indexed keywords

CORE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL NUCLEUS; CELL VACUOLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; HEART LEFT VENTRICLE FAILURE; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEPATITIS C VIRUS; HYPERTROPHY; MOUSE; MUSCLE FIBRIL; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS CORE; VIRUS GENE; VIRUS INFECTION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BODY WEIGHT; ECHOCARDIOGRAPHY, DOPPLER; FIBROSIS; GENE EXPRESSION REGULATION, VIRAL; HEPACIVIRUS; HEPATITIS C; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; MICE, TRANSGENIC; MICROFILAMENTS; MITOCHONDRIA, HEART; MYOCARDITIS; MYOCARDIUM; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; NF-KAPPA B; ORGAN SIZE; RNA, MESSENGER; RNA, VIRAL; TRANSCRIPTION FACTOR AP-1; VENTRICULAR DYSFUNCTION, LEFT; VIRAL CORE PROTEINS;

EID: 13444250886     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000154263.70223.13     Document Type: Article

References (14)

1. Mayo MJ. Extrahepatic manifestations of hepatitis C infection. Am J Med Sci. 2003;325:135-148.
2. Nagao Y, Sata M, Fukuizumi K, Ryu F, Ueno T. High incidence of oral lichen planus in an HCV hyperendemic area. Gastroenterology. 2000; 119:882-883.
3. Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, Regnier D, Dreyfus G, Pradier C, Sadoul JL, et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology. 1993;18:253-257.
4. Matsumori A, Matoba Y, Sasayama S. Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation. 1995;92:2519-2525.
5. Matsumori A, Matoba Y, Nishio R, Shioi T, Ono K, Sasayama S. Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun. 1996;222: 678-682.
6. Honda A, Hatano M, Kohara M, Arai Y, Hartatik T, Moriyama T, Imawari M, Koike K, Yokosuka O, Shimotohno K, Tokuhisa T. HCV-core protein accelerates recovery from the insensitivity of liver cells to Fas-mediated apoptosis induced by an injection of anti-Fas antibody in mice. J Hepatol. 2000;33:440-447.
7. Yoshiyama M, Omura T, Takeuchi K, Kim S, Shimada K, Yamagishi H, Teragaki M, Akioka K, Iwao H, Yoshikawa J. Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA- binding activities in myocardial infsrcted rats. J Mol Cell Cardiol. 2001;33:799-810.
8. Ishida S, Kaito M, Kohara M, Tsukiyama-Kohora K, Fujita N, Ikoma J, Adachi Y, Watanabe S. Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation technique. Hepatol Res. 2001;20:335-347.
9. Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol. 1996;70:4438-4443.
10. Tsutsumi T, Suzuki T, Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Matsuura Y, Kimura S, Koike K, Miyamura T. Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein. Virology. 2002;304:415-424.
11. Omura T, Yoshiyama M, Yoshida K, Nakamura Y, Kim S, Iwao H, Takeuchi K, Yoshikawa J. Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine. Hypertension. 2002;39:81-86.
12. Leatherbury L, Chandra RS, Shapiro SR, Perry LW. Value of endomyocardial biopsy in infants, children and adolescents with dilated or hypertrophic cardiomyopathy and myocarditis. J Am Coll Cardiol. 1988;12: 1547-1554.
13. Arbustini E, Diegoli M, Fasani R, Grasso M, Morbini P, Banchieri N, Bellini O, Dal Bello B, Pilotto A, Magrini G, Campana C, Fortina P, Gavazzi A, Narula J, Vigano M. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol. 1998;153:1501-1510.
14. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med. 1998;4:1065-1067.